267 related articles for article (PubMed ID: 32286246)
1. COVID-19 infections are also affected by human ACE1 D/I polymorphism.
Delanghe JR; Speeckaert MM; De Buyzere ML
Clin Chem Lab Med; 2020 Jun; 58(7):1125-1126. PubMed ID: 32286246
[No Abstract] [Full Text] [Related]
2. Could angiotensin-converting enzyme 1
Dević Pavlić S; Nadalin S; Starčević Čizmarević N; Buretić-Tomljanović A; Radojčić Badovinac A; Ristić S
J Renin Angiotensin Aldosterone Syst; 2020; 21(3):1470320320957157. PubMed ID: 32928023
[No Abstract] [Full Text] [Related]
3. A suspicious role of interferon in the pathogenesis of SARS-CoV-2 by enhancing expression of ACE2.
Su S; Jiang S
Signal Transduct Target Ther; 2020 May; 5(1):71. PubMed ID: 32435059
[No Abstract] [Full Text] [Related]
4. Sex-mediated effects of ACE2 and TMPRSS2 on the incidence and severity of COVID-19; The need for genetic implementation.
Alshahawey M; Raslan M; Sabri N
Curr Res Transl Med; 2020 Nov; 68(4):149-150. PubMed ID: 32917573
[No Abstract] [Full Text] [Related]
5. Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome.
Gómez J; Albaiceta GM; García-Clemente M; López-Larrea C; Amado-Rodríguez L; Lopez-Alonso I; Hermida T; Enriquez AI; Herrero P; Melón S; Alvarez-Argüelles ME; Boga JA; Rojo-Alba S; Cuesta-Llavona E; Alvarez V; Lorca R; Coto E
Gene; 2020 Dec; 762():145102. PubMed ID: 32882331
[TBL] [Abstract][Full Text] [Related]
6. Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19.
Tsiambas E; Papanikolaou V; Chrysovergis A; Mastronikolis N; Ragos V; Kavantzas N; Lazaris AC; Kyrodimos E
Pathol Oncol Res; 2020 Oct; 26(4):2823-2825. PubMed ID: 32333199
[No Abstract] [Full Text] [Related]
7. Host Polymorphisms May Impact SARS-CoV-2 Infectivity.
Brest P; Refae S; Mograbi B; Hofman P; Milano G
Trends Genet; 2020 Nov; 36(11):813-815. PubMed ID: 32828550
[TBL] [Abstract][Full Text] [Related]
8. The host's angiotensin-converting enzyme polymorphism may explain epidemiological findings in COVID-19 infections.
Delanghe JR; Speeckaert MM; De Buyzere ML
Clin Chim Acta; 2020 Jun; 505():192-193. PubMed ID: 32220422
[No Abstract] [Full Text] [Related]
9. SARS-CoV-2 Infections: An ACE in the Hole and Systems Biology Studies-a Research Agenda.
Poland GA; Bass J; Goldstein MR
Mayo Clin Proc; 2020 Sep; 95(9):1838-1841. PubMed ID: 32861326
[No Abstract] [Full Text] [Related]
10. SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1 I/D genotype.
Yamamoto N; Ariumi Y; Nishida N; Yamamoto R; Bauer G; Gojobori T; Shimotohno K; Mizokami M
Gene; 2020 Oct; 758():144944. PubMed ID: 32628976
[TBL] [Abstract][Full Text] [Related]
11. [Genetic and epigenetic variability, and the Covid-19 pandemic].
Rivera-Silva G
Salud Publica Mex; 2020; 62(5):462-463. PubMed ID: 32668509
[No Abstract] [Full Text] [Related]
12. [Are there genetic variants that can modify the course of the COVID-19 pandemic?].
Azurmendi PJ
Medicina (B Aires); 2020; 80 Suppl 3():79-81. PubMed ID: 32658852
[No Abstract] [Full Text] [Related]
13. Genetic predisposition models to COVID-19 infection.
Darbeheshti F; Rezaei N
Med Hypotheses; 2020 Sep; 142():109818. PubMed ID: 32416414
[No Abstract] [Full Text] [Related]
14. ACE2 Expression and Risk Factors for COVID-19 Severity in Patients with Advanced Age.
Tavares CAM; Avelino-Silva TJ; Benard G; Cardozo FAM; Fernandes JR; Girardi ACC; Jacob Filho W
Arq Bras Cardiol; 2020 Oct; 115(4):701-707. PubMed ID: 33111872
[No Abstract] [Full Text] [Related]
15. Sex-derived attributes contributing to SARS-CoV-2 mortality.
Chanana N; Palmo T; Sharma K; Kumar R; Graham BB; Pasha Q
Am J Physiol Endocrinol Metab; 2020 Sep; 319(3):E562-E567. PubMed ID: 32726128
[TBL] [Abstract][Full Text] [Related]
16. Can estrogens protect against COVID-19? The COVID-19 puzzling and gender medicine.
Bonaccorsi G; Gambacciani M; Gemmati D
Minerva Ginecol; 2020 Jun; 72(3):178-179. PubMed ID: 33000616
[No Abstract] [Full Text] [Related]
17. Multiomics Evaluation of Gastrointestinal and Other Clinical Characteristics of COVID-19.
Du M; Cai G; Chen F; Christiani DC; Zhang Z; Wang M
Gastroenterology; 2020 Jun; 158(8):2298-2301.e7. PubMed ID: 32234303
[No Abstract] [Full Text] [Related]
18. ACE polymorphisms and COVID-19-related mortality in Europe.
Bellone M; Calvisi SL
J Mol Med (Berl); 2020 Nov; 98(11):1505-1509. PubMed ID: 32935155
[No Abstract] [Full Text] [Related]
19. Covid-19 infection and the host genetic predisposition: does it exist?
Vašků A
Physiol Res; 2020 Jul; 69(3):511-514. PubMed ID: 32682363
[TBL] [Abstract][Full Text] [Related]
20. The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues.
Darbani B
Int J Environ Res Public Health; 2020 May; 17(10):. PubMed ID: 32423095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
